126 related articles for article (PubMed ID: 2438152)
21. Conformation and immunogenicity of engineered repeating segment of the circumsporozoite surface protein of Plasmodium falciparum.
Armah GE; Nishikawa S; Miki S; Omata Y; Nakabayashi T; Tomita K
Mol Biochem Parasitol; 1990 Jan; 38(1):135-40. PubMed ID: 2181302
[TBL] [Abstract][Full Text] [Related]
22. Immunogenicity of a hybrid Plasmodium falciparum malaria antigen.
Lockyer MJ; Cooper H; Tite J; Rowan W; Crowe JS
Parasitology; 1993 Jun; 106 ( Pt 5)():451-7. PubMed ID: 8341580
[TBL] [Abstract][Full Text] [Related]
23. Synthetic peptide immunogens eliciting antibodies to Plasmodium falciparum sporozoite and merozoite surface antigens in H-2b and H-2k mice.
Rzepczyk CM; Csurhes PA; Lord R; Matile H
J Immunol; 1990 Oct; 145(8):2691-6. PubMed ID: 2212657
[TBL] [Abstract][Full Text] [Related]
24. A linear peptide containing minimal T- and B-cell epitopes of Plasmodium falciparum circumsporozoite protein elicits protection against transgenic sporozoite challenge.
Calvo-Calle JM; Oliveira GA; Watta CO; Soverow J; Parra-Lopez C; Nardin EH
Infect Immun; 2006 Dec; 74(12):6929-39. PubMed ID: 17030584
[TBL] [Abstract][Full Text] [Related]
25. Synthetic peptides as antigens for the detection of humoral immunity to Plasmodium falciparum sporozoites.
Zavala F; Tam JP; Masuda A
J Immunol Methods; 1986 Oct; 93(1):55-61. PubMed ID: 3534091
[TBL] [Abstract][Full Text] [Related]
26. Molecular dissection of the human antibody response to the structural repeat epitope of Plasmodium falciparum sporozoite from a protected donor.
Chappel JA; Rogers WO; Hoffman SL; Kang AS
Malar J; 2004 Jul; 3():28. PubMed ID: 15283866
[TBL] [Abstract][Full Text] [Related]
27. A protective monoclonal antibody with dual specificity for Plasmodium falciparum and Plasmodium berghei circumsporozoite proteins.
Sina BJ; Wright C; Ballou R; Hollingdale M
Exp Parasitol; 1992 Jun; 74(4):431-40. PubMed ID: 1375561
[TBL] [Abstract][Full Text] [Related]
28. Comparing Antibody Responses in Chickens Against Plasmodium falciparum Lactate Dehydrogenase and Glyceraldehyde-3-phosphate Dehydrogenase with Freund's and Pheroid® Adjuvants.
Krause RG; Grobler AF; Goldring JP
Immunol Invest; 2015; 44(7):627-42. PubMed ID: 26436851
[TBL] [Abstract][Full Text] [Related]
29. T cell responses to repeat and non-repeat regions of the circumsporozoite protein detected in volunteers immunized with Plasmodium falciparum sporozoites.
Nardin E; Munesinghe YD; Moreno A; Clavijo P; Calle MC; Edelman R; Davis J; Herrington D; Nussenzweig RS
Mem Inst Oswaldo Cruz; 1992; 87 Suppl 3():223-7. PubMed ID: 1364202
[TBL] [Abstract][Full Text] [Related]
30. Conformational analysis of the immunodominant epitopes of the circumsporozoite protein of Plasmodium falciparum and knowlesi.
Fasman GD; Park K; Schlesinger DH
Biopolymers; 1990 Jan; 29(1):123-30. PubMed ID: 1691663
[TBL] [Abstract][Full Text] [Related]
31. Induction of cytotoxic T lymphocytes against the Plasmodium falciparum circumsporozoite protein by immunization with soluble recombinant protein without adjuvant.
Malik A; Gross M; Ulrich T; Hoffman SL
Infect Immun; 1993 Dec; 61(12):5062-6. PubMed ID: 8225583
[TBL] [Abstract][Full Text] [Related]
32. Safety and efficacy of a recombinant DNA Plasmodium falciparum sporozoite vaccine.
Ballou WR; Hoffman SL; Sherwood JA; Hollingdale MR; Neva FA; Hockmeyer WT; Gordon DM; Schneider I; Wirtz RA; Young JF
Lancet; 1987 Jun; 1(8545):1277-81. PubMed ID: 2884410
[TBL] [Abstract][Full Text] [Related]
33. Antibodies to the repetitive epitope of Plasmodium falciparum circumsporozoite protein in a rural Tanzanian community: a longitudinal study of 132 children.
Del Giudice G; Engers HD; Tougne C; Biro SS; Weiss N; Verdini AS; Pessi A; Degremont AA; Freyvogel TA; Lambert PH
Am J Trop Med Hyg; 1987 Mar; 36(2):203-12. PubMed ID: 2435181
[TBL] [Abstract][Full Text] [Related]
34. Immunogenicity of well-characterized synthetic Plasmodium falciparum multiple antigen peptide conjugates.
Joshi MB; Gam AA; Boykins RA; Kumar S; Sacci J; Hoffman SL; Nakhasi HL; Kenney RT
Infect Immun; 2001 Aug; 69(8):4884-90. PubMed ID: 11447164
[TBL] [Abstract][Full Text] [Related]
35. Comparison of antibody avidity and titre elicited by peptide as a protein conjugate or as expressed in vaccinia.
Lew AM; Anders RF; Edwards SJ; Langford CJ
Immunology; 1988 Oct; 65(2):311-4. PubMed ID: 3056855
[TBL] [Abstract][Full Text] [Related]
36. Peptide immunization can elicit malaria protein-specific memory helper but not proliferative T cells.
Good MF; Branigan J; Smith G; Houghten RA
Pept Res; 1990; 3(3):110-5. PubMed ID: 1724615
[TBL] [Abstract][Full Text] [Related]
37. Cellular and humoral immune responses to a recombinant P. falciparum CS protein in sporozoite-immunized rodents and human volunteers.
Nardin EH; Nussenzweig RS; Altszuler R; Herrington D; Levine M; Murphy J; Davis J; Bathurst I; Barr P; Romero P
Bull World Health Organ; 1990; 68 Suppl(Suppl):85-7. PubMed ID: 2094595
[TBL] [Abstract][Full Text] [Related]
38. Predicted conformations for the immunodominant region of the circumsporozoite protein of the human malaria parasite Plasmodium falciparum.
Gibson KD; Scheraga HA
Proc Natl Acad Sci U S A; 1986 Aug; 83(15):5649-53. PubMed ID: 2426702
[TBL] [Abstract][Full Text] [Related]
39. Antigenic analysis of the repeat domain of the circumsporozoite protein of Plasmodium vivax.
Romero P; Heimer EP; Herrera S; Felix AM; Nussenzweig RS; Zavala F
J Immunol; 1987 Sep; 139(5):1679-82. PubMed ID: 2442254
[TBL] [Abstract][Full Text] [Related]
40. Immunization trials with the ring-infected erythrocyte surface antigen of Plasmodium falciparum in owl monkeys (Aotus vociferans).
Collins WE; Pappaioanou M; Anders RF; Campbell GH; Brown GV; Kemp DJ; Broderson JR; Coppel RL; Skinner JC; Procell PM
Am J Trop Med Hyg; 1988 Mar; 38(2):268-82. PubMed ID: 3281493
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
